Dossier
Michael Hiltzik
Coverage of Michael Hiltzik in the Nexus archive.
- Hiltzik: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people
Gilead's HIV drug lenacapavir has the potential to transform HIV treatment, but the company is preventing millions of low-income patients from accessing it. The article criticizes the pharmaceutical company for prioritizing profit over equitable distribution.
- Hiltzik: Exploring the moon while cutting NASA? Why Trump's 2027 budget misfires
Trump's 2027 budget proposal targets NASA and programs aimed at improving American education, health, and safety. The article critiques the plan as misaligned with public interest, questioning Trump's underlying agenda.
- Hiltzik: Here are all the good things we could buy for the billions Trump is spending on his Iran war
Trump has allocated over $25 billion for his Iran war and seeks an additional $200 billion. The article highlights potential alternative uses for these funds.